|
Public Citizen Calls for Boxed Warning on Top-Selling Hypertension Drugs
Public Citizen is urging the FDA to require boxed warnings on the labels of many top-selling hypertension drugs, including angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs) and Novartis’ aliskiren, to warn against their use in combination.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives